Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 1167557 Greenwich, CT
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,899,532
-$514,099 QoQ
Shares Held
542,178
+22.2% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 242 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. SMMT ranks #65 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in SMMT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,899,532 542,178
2026-03-31 $8,413,631 443,757
2025-12-31 $6,259,145 357,870
2025-09-30 $3,873,418 187,484
2025-06-30 $474,798 22,312
2025-03-31 $1,265,866 65,623
2024-12-31 $1,115,115 62,489
2024-09-30 $1,500,543 68,518
2024-06-30 $484,488 62,114
2023-09-30 $35,950 19,225